drug · antibody
visugromab
Phase 2updated 3mo agoby Catalym GmbH🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 2 3, with 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying visugromab
- phase2Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer
- phase2First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER)
- phase3Visugromab in Cachexia International Trial
- phase2Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
- phase2Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
- phase2Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that